Spirulina and pernicious anaemia: intrinsic factor deficiency, B12 pseudocobalamin trap, and combined deficiency

Pernicious anaemia: mechanism and diagnosis

Autoimmune parietal cell destruction: Anti-parietal cell antibodies (present in ~90% of PA patients) destroy gastric parietal cells, eliminating hydrochloric acid and intrinsic factor (IF) secretion. Without IF, the ileal cubilin/amnionless receptor complex cannot bind the IF-B12 complex, and dietary B12 is not absorbed. Anti-IF antibodies (present in ~60% of PA) directly block IF-B12 binding.
Without intrinsic factor, only ~1% passive B12 absorption remains: High-dose oral cyanocobalamin (1,000 µg/day) can maintain B12 status via this passive route — which is why high-dose oral B12 works for PA, though IM injection bypasses the problem entirely. Spirulina pseudocobalamin cannot use this passive route effectively to correct B12 deficiency.
Gastric atrophy and dual deficiency: Gastric acid is required to cleave food-bound B12 from dietary protein (pepsin) and to convert dietary iron to the ferrous (Fe²+) form for duodenal absorption. Achlorhydria from parietal cell loss impairs both B12 and iron absorption. Iron deficiency anaemia coexisting with B12 deficiency is common in PA; the blood count may appear near-normal (microcytic iron deficiency anaemia partially cancels the macrocytosis of B12 deficiency) — the so-called “dimorphic blood picture.”

In pernicious anaemia, B12 monitoring by serum B12 assay is already a known challenge (IM hydroxycobalamin can produce artificially elevated serum B12 levels for weeks). Adding spirulina pseudocobalamin to this picture makes serum B12 monitoring useless — the assay will show high values driven by pseudocobalamin while the patient may be functionally deficient.
Patients with PA who take spirulina for its non-B12 benefits (iron, protein, anti-inflammatory) must inform their haematologist and ensure B12 status is monitored exclusively via MMA (methylmalonic acid) and holotranscobalamin II — not serum B12 total immunoassay.
If spirulina is the only supplement being taken and a GP checks a “B12 level” on a standard assay: the result will appear falsely elevated. The GP may conclude B12 is adequate and delay diagnosis or treatment. This is not theoretical — it is a documented diagnostic pitfall.

Iron for concurrent iron deficiency: Achlorhydria impairs dietary iron absorption. Spirulina non-haem iron (2–4 mg/5 g) provides a useful dietary source. In PA with confirmed iron deficiency (transferrin saturation <20%, low ferritin): spirulina iron contributes but significant deficiency requires dedicated iron supplementation (ferrous sulphate or IV iron).
The acid-independent iron absorption advantage: Spirulina iron is incorporated within the cellular matrix of the algae; a proportion of this iron may be accessible via proteolytic digestion rather than requiring gastric acid for ionisation from food matrix. This is not well-established but may provide modest advantage over standard non-haem iron in achlorhydric patients.
Anti-inflammatory in autoimmune gastritis: Gastric mucosal NOX2 activation contributes to ongoing parietal cell oxidative damage. Phycocyanobilin’s NOX2 inhibition may reduce this ongoing atrophy, though no clinical data exists for spirulina in PA.

B12 monitoring rule: If taking spirulina and diagnosed with PA, insist on MMA and holotranscobalamin II for B12 monitoring — not serum B12 total. Tell your haematologist you take spirulina; this affects the choice of monitoring assay.
B12 replacement in PA is non-negotiable: IM hydroxycobalamin (1,000 µg every 3 months in UK standard practice) or high-dose oral cyanocobalamin (1,000 µg/day). Spirulina provides zero contribution to B12 repletion.
Iron status: check transferrin saturation and ferritin alongside B12 monitoring; concurrent iron deficiency is common and often undertreated in PA
3–5 g/day spirulina is safe in PA from a drug-interaction perspective. The only concern is B12 assay interference — addressed by using MMA/holoTC.
No interaction with IM hydroxycobalamin or high-dose oral cyanocobalamin; no interaction with iron supplements (do not take simultaneously with iron supplements — take spirulina in the morning and iron separately if prescribed)